IVEXSOL VECTOR FITNESS TESTING Trademark

Trademark Overview

On Saturday, November 6, 2021, a trademark application was filed for IVEXSOL VECTOR FITNESS TESTING with the United States Patent and Trademark Office. The USPTO has given the IVEXSOL VECTOR FITNESS TESTING trademark a serial number of 97977527. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Thursday, April 18, 2024. This trademark is owned by iVexSol Inc.. The IVEXSOL VECTOR FITNESS TESTING trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Treatment of materials in the nature of cells, viruses, and biological membranes to obtain carriers for gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Treatment of materials, namely, the conversion of cells, viruses, and biological membranes into biochemical preparations; Custom manufacturing of biological substances, materials, and preparations; Custom manufacturing of cells, viruses, viral vectors, viral constructs and biological membranes; Manufacturing and processing for others of cells, viruses, viral vectors, viral constructs and biological membranes for third parties; Manufacturing and processing for others of gene therapy products, pharmaceuticals, biopharmaceuticals, biological preparations and vaccines; Processing of biological and generic material for others
ivexsol vector fitness testing

General Information

Serial Number97977527
Word MarkIVEXSOL VECTOR FITNESS TESTING
Filing DateSaturday, November 6, 2021
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateThursday, April 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements

Goods and ServicesTreatment of materials in the nature of cells, viruses, and biological membranes to obtain carriers for gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Treatment of materials, namely, the conversion of cells, viruses, and biological membranes into biochemical preparations; Custom manufacturing of biological substances, materials, and preparations; Custom manufacturing of cells, viruses, viral vectors, viral constructs and biological membranes; Manufacturing and processing for others of cells, viruses, viral vectors, viral constructs and biological membranes for third parties; Manufacturing and processing for others of gene therapy products, pharmaceuticals, biopharmaceuticals, biological preparations and vaccines; Processing of biological and generic material for others
NOT AVAILABLE"VECTOR FITNESS TESTING"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, October 5, 2022
Primary Code040
First Use Anywhere DateTuesday, November 30, 2021
First Use In Commerce DateTuesday, November 30, 2021

Trademark Owner History

Party NameiVexSol Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWorcester, US 01605
Party NameiVexSol Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWorcester, US 01605

Trademark Events

Event DateEvent Description
Thursday, August 18, 2022NON-FINAL ACTION WRITTEN
Wednesday, November 10, 2021NEW APPLICATION ENTERED
Tuesday, November 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 17, 2022ASSIGNED TO EXAMINER
Thursday, August 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 18, 2022NON-FINAL ACTION E-MAILED
Wednesday, October 5, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 5, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 5, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, October 5, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, October 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 8, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 8, 2023SOU EXTENSION 1 FILED
Thursday, June 8, 2023SOU EXTENSION 1 GRANTED
Saturday, June 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 15, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 15, 2023SOU EXTENSION 2 FILED
Friday, December 15, 2023SOU EXTENSION 2 GRANTED
Tuesday, December 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2023TEAS REQUEST TO DIVIDE RECEIVED
Friday, December 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 27, 2023REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
Wednesday, February 7, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, February 7, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, February 7, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, February 7, 2024USE AMENDMENT FILED
Wednesday, February 21, 2024DIVISIONAL PROCESSING COMPLETE
Wednesday, February 21, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 18, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, April 18, 2024NON-FINAL ACTION E-MAILED
Thursday, April 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

testing fitness vector ivexsol biological viral manufacturing viruses membranes cells preparations others materials processing